Objective. Th e aim of the present study was to examine the eff ect of chromium disilicide and titanium nitride nanoparticles on the expression level of genes encoding important regulatory factors (IGFBP1, IGFBP2, IGFBP3, IGFBP4, IGFBP5, SNARK/NUAK2, CD36, and PECAM1/CD31) in mouse liver for evaluation of possible toxic eff ects of these nanoparticles.
about the toxicity, including genotoxicity, induced by these nanoparticles (van Hove et al. 2015; Chu et al. 2016; Karjalainen and Nammas 2016; Ritz et al. 2016) . At the same time, for ultrafi ne titanium dioxide nanoparticles, which are widely used in the number of applications, including white pigment in paint, ceramics, food packaging materials, food additives, cosmetic creams, toothpastes, and components of surgical implants, it has been shown that the longterm exposure to titanium dioxide nanoparticles led to their accumulation in brain, oxidative stress, overproliferation of all glial cells, tissue necrosis as well as hippocampal cell apoptosis, which resulted in neurogenic disease states in mice (Ze et al. 2014; Rollerova et al. 2015) . Signifi cant changes in brain gene expressions were also found: increases in collagen A1 (CO-L1A1), serine/threonine-protein kinase 1 (AKT1), catenin beta 1 (CTNNB1), cysteine and serine rich nuclear protein 1 (CSRNP1), DDIT4 (DNA damage inducible transcript 4), cytochrome P450 family 2 subfamily E member 1 (CYP2E1), and Krev interaction trapped protein 1 (KRIT1) expressions and great decreases in dopamine receptor D2 (DRD2), neuraminidase 1 (NEU1), Fc receptor-like A (FCRLA), and 7-dehydrocholesterol reductase (DHCR7) expressions (Ze et al. 2014) . Furthermore, Yang et al. (2016) have shown that oral administration of titanium dioxide nanoparticles disrupts hepatic metabolic functions in a mouse model. Recently, it has been shown that titanium dioxide nanoparticles have possible impact on health due to their specifi c properties supported by their size and geometry (Simon et al. 2017 ). Th ese nanoparticles, which were synthesized as nanoneedles, titanate scrolled nanosheets, and gelsol-based isotropic nanoparticle, were internalized at various degrees and their toxicity depended on both the titanium content and nanoparticles shape. Diverse titanium dioxide nanoparticles aff ect intracellular calcium homeostasis, thereby leading to endoplasmic reticulum stress-dependent toxicity (Simon et al. 2017) . Th ere are data that chromium disilicide nanowires are attractive choices for future applications in magnetic storage, photovoltaic, and fi eld emitters (Hsu et al. 2015) , but the toxicity of chromium disilicide nanoparticles has not been studied yet. Recently, Alarifi et al. (2016) have shown that chromium oxide nanoparticles had signifi cant cytotoxic effects on murine fi brosarcoma cells. At the same time, there are data that chromium is well-established human carcinogen causing various cancers upon long term exposure (Humphries et al. 2016) and that quercetin inhibits chromium-induced malignant cell transformation (Pratheeshkumar et al. 2016) .
Th e insulin-like growth factor binding proteins (IGFBPs) as extracellular matrix proteins bind and regulate the availability of both IGFs and inhibit or stimulate the growth promoting eff ects of the IGFs through IGF/INS receptors and through other signaling pathways. Although the primary site of action of ECM proteins is extracellular, evidence is emerging for non-canonical intracellular roles of IGFBPs, which regulate cell proliferation and survival as well as tumor angiogenesis and cell migration Bach 2015; Hellewell and Adams 2016; . IGFBPs are now understood to have many actions beyond their endocrine role in the transport of IGF Bach 2015) . Additionally, IGFBPs bind non-IGF ligands in the extracellular space, cell membrane, cytoplasm and nucleus, thereby modulating cell proliferation, survival and migration in an IGF-independent manner. Both IGFBP1 and IGFBP2 preferentially stimulate tumor growth through variable mechanisms. Th us, Kim et al. (2016) have shown that IGFBP1 and ALDH1A1 are diff erentially overexpressed in the colorectal cancer liver metastasis and may play a dual role, functioning as both tumor suppressors and metastasis promoters in colorectal cancer. Furthermore, there are data that glioblastoma-derived MCSF (macrophage colony-stimulating factor) induces microglial release of IGFBP1 to promote angiogenesis (Nijaguna et al. 2015) . IGFBP2 is highly up-regulated in glioblastoma tissues. It has been also shown that exogenous IGFBP2 promotes proliferation and invasion in glioma cells via the integrin β1-ERK pathway and that this IGFBP with MDA9/syntenin promotes angiogenesis in human melanoma (Han et al. 2014) . Moreover, IGFBP2 enhances VEGF gene promoter activity and consequent promotion of angiogenesis by neuroblastoma cells . Recently, Phillips et al. (2016) revealed that IGFBP2 not only is a driver of glioma progression and a prognostic factor but also is also required for tumor maintenance and can be blocked using anti-IGFBP2 strategies. Furthermore, cell viability during glucose deprivation is enhances by TRIB3 (pseudokinase Tribbles homolog 3) through upregulation of IGFBP2, which is recognized as a novel nutrient defi ciency survival factor (Ord et al. 2015) . IGFBP3 is an N-linked glycosylated, phosphorylated protein, which has been reported to regulate cancer growth because it has proapoptotic and growth-inhibitory actions as well as cytoprotective and growth-potentiating properties (Johnson and Firth 2014) . Th is protein participates in transcription, cell-stress responses, autophagy and cancer (Hellewell and Adams 2016) . Antiprolif-erative and apoptotic eff ects of IGFBP3 are IGF-independent and mediated by its receptor TMEM219 and within the nucleus IGFBP3 appears to have a role in transcriptional regulation (Ingermann et al. 2010; Baxter 2015; Ranke 2015) . IGFBP-3 is TP53-inducible and in response to DNA damage, forms a complex with the epidermal growth factor receptor (EGFR), translocating to the nucleus to interact with DNAdependent protein kinase (Baxter 2015) . It is interesting to note that IGFBP1, IGFBP2, and IGFBP3 are linked to insulin resistance, obesity, and the type 2 diabetes mellitus, and metabolic syndrome, because they are at the interface of growth and metabolism (Sabin et al. 2011; Gokulakrishnan et al. 2012; Kim and Lee 2015) .
Th us, IGFBP4 preferentially binds to IGF2 and regulates growth and development of tissues and organs by negatively regulating IGF signaling. It has also IGF-independent eff ects including inhibition of angiogenesis and promotion of cancer cell migration (Praveen Kumar et al. 2014) . Among most cancers, IGFBP4 has growth inhibitory role and is reported as a down-regulated gene, except for renal cell carcinoma and some gliomas, wherein it promotes tumor progression (Praveen Kumar et al. 2014 ). Th us, IGFBP4 modulates ligand-dependent estrogen receptor-alpha activation in breast cancer cells in an IGF-independent manner through activation of the Akt/PKB signaling pathway (Hermani et al. 2013) . Recently, it has been shown that inhibition of tumor-associated αvβ3 integrin regulates the angiogenic switch by enhancing the expression of IGFBP4, an important negative regulator of IGF-1 signaling, leading to reduced melanoma growth and angiogenesis in vivo (Contois et al. 2015) . Th e IGFBP5, which is oft en dysregulated in human cancers, plays a crucial role in the carcinogenesis and cancer development, preferentially acts as an important tumor suppressor, and the proliferation of IGFBP5-mutated cancer cells is selectively blocked by IGF-1R inhibitors (Wang et al. 2015; Ding et al. 2016) . Overexpression of IGFBP5 suppresses epithelial-mesenchymal transition and decreases the expression of E-cadherin, exerts its inhibitory activities by reducing the phosphorylation of IGF1R, ERK1/2, and p38-MAPK kinases and abating the expression of HIF1α and its target genes, VEGF and MMP9 (Wang et al. 2015; Hwang et al. 2016) .
SNARK (SNF1/AMP kinase-related kinase), also known as NUAK2 (NUAK family SNF1-like kinase 2), is a stress-activated kinase involved in tolerance to glucose starvation, induces cell-cell detachment by increasing F-actin conversion to G-actin, participates in the control of cell proliferation and apoptosis (Namiki et al. 2011; Liu et al. 2012; Sun et al. 2013) . Furthermore, miR-143 inhibits oncogenic traits by degrading NUAK2 in glioblastoma because this miRNA as well as miR-1 directly regulate NUAK2 oncogene (Fu et al. 2016; Miller et al. 2016 ). CD36 (cluster determinant 36), also known as leukocyte diff erentiation antigen CD36, thrombospondin receptor, collagen type I receptor, and FAT (fatty acid translocase), seems to have numerous potential physiological functions (Pascual et al. 2017) . CD36 functions as a cell adhesion molecule and its inhibition impairs metastasis. Recently, it has been shown that exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins CD36 and FABP5 in MCF-7 breast cancer cells (Guaita-Esteruelas et al. 2017) . CD36 gene may also play some role in the pathogenesis of impaired fasting glucose/impaired glucose tolerance and type 2 diabetes (Wang et al. 2012) . PECAM1 (platelet and endothelial cell adhesion molecule 1), also known as CD31, is involved in angiogenesis, leukocyte migration, and integrin activation and its enhanced expression correlates with hypoxia inducible factor-1α in human glioblastoma multiforme (Avci et al. 2015; Musumeci et al. 2015; Ilhan-Mutlu et al. 2016 ).
Previously, we have shown that C 60 fullerene and cerium dioxide nanoparticles aff ect the expression of some endoplasmic reticulum stress response genes, which are linked to cell proliferation, cell survival and death processes (Minchenko et al. 2013a,b) . Multiple studies have clarifi ed the link between endoplasmic reticulum stress, which controls numerous processes including cell proliferation and survival and various diseases including cancer and metabolic diseases (Bravo et al. 2013; Manie et al. 2014; Chevet et al. 2015; Dejeans et al. 2015) . It is possible that long-term treatment of mice with chromium disilicide and titanium dioxide nanoparticles also led to endoplasmic reticulum stress and altered the expression of stress related genes, which are integrated into the unfolded protein response signaling pathways and regulate cell proliferation and apoptosis.
Th e main goal of this work was to study the effect of chromium disilicide and titanium nitride nanoparticles on the expression level of genes encoding important regulatory factors and enzymes (IGFBP1, IGFBP2, IGFBP3, IGFBP4, IGFBP5, PECAM1, CD36, and SNARK) in mouse liver for evaluation of possible genotoxic eff ects of these nanoparticles.
Materials and Methods
Nanoparticles and treatment conditions. Titanium nitride and chromium disilicide nanoparticles were produced by prof. A.V. Ragulya at I.M. Frantsevich Institute for Problems of Materials Science of the National Academy of Sciences of Ukraine. Titanium nitride nanoparticles have medium size of 20 nm and can create conglomerates (Figures 1, 2) . Chromium disilicide nanoparticles have medium size of 45 nm and also can create conglomerates (Figures 1, 2) . For the study, we used 60 age-matched male mice, which were kept in the animal facilities of Bohomolets National Medical University and housed in a quiet, temperature controlled room, and were provided with water and dry food pellets ad libitum. Before removing the liver, mice were sacrifi ced by cervical dislocation. All procedures conformed to the guidelines of the Bohomolets National Medical University. For treatment by nanoparticles, animals received 20 mg titanium nitride or chromium disilicide nanoparticles with food every working day for 2 months. Before usage, both titanium nitride and chromium disilicide nanoparticles were treated by special procedure for disruption of conglomerates.
RNA isolation. Frozen liver tissue (100 mg) was homogenized into 0.4 ml of Trizol reagent (Invitrogen, Carlsbad, CA, U.S.A.) and total RNA was extracted according to manufacturer's protocol. RNA pellets were washed with 75% ethanol and dissolved in nuclease-free water. For additional purifi cation, RNA samples were re-precipitated with 95% ethanol and re-dissolved again in nuclease-free water. RNA concentration and spectral characteristics were measured using NanoDrop Spectrophotometer ND1000 (PEQLAB, Biotechnologie GmbH).
Reverse transcription and quantitative PCR analysis. Th e expression levels of IGFBP1, IGFBP2, IGFBP3, IGFBP4, IGFBP5, SNARK/NUAK2, CD31/ PECAM1, and CD36 mRNAs as well as ACTB mRNA were measured in liver tissue of control mice and animals treated by chromium disilicide and titanium nitride nanoparticles (4 mice in each group) using realtime quantitative polymerase chain reaction. Th ermo Scientifi c Verso cDNA Synthesis Kit (Lithuania) was used for cDNA synthesis according to manufacturer's protocol. Maxima SYBR Green/ROX qPCR Master Mix (Th ermo Fisher Scientifi c, U.S.A.) and "7500 HT Fast Real-Time PCR System" (Applied Biosystems, U.S.A.) were used for amplifi cation. Polymerase chain reaction was performed in triplicates.
Th e amplifi cation of IGFBP1 cDNA for real time RCR analysis was performed using two oligonucleotides primers: forward -5'-agatcgccgacctcaagaaa-3' Figure 1 . Th e scanning electron microscopy images of titanium nitride (TiN) and chromium disilicide (CrSi 2 ) nanoparticles. and reverse -5'-ccagggatgtctcacactgt-3'. Th e nucleotide sequences of these primers correspond to sequences 705-724 and 875-856 of mouse IGFBP1 cDNA (GenBank accession number NM_008341). For amplifi cation of IGFBP2 cDNA, we used forward (5'-catccccaactgtgacaagc-3' and reverse (5'-tcctgctgctcgttgtagaa-3') primers. Th e nucleotide sequences of these primers correspond to sequences 811-830 and 984-965 of mouse IGFBP2 cDNA (GenBank accession number NM_008342). Th e amplifi cation of IGFBP3 cDNA for real time RCR analysis was performed using two oligonucleotides primers: forward -5'-cgtccacatcccaaactgtg-3' and reverse -5'-tgaggcaatgtacgtcgtct-3'. Th e nucleotide sequences of these primers correspond to sequences 838-857 and 945-926 of mouse IGFBP3 cDNA (GenBank accession number NM_008343). For amplifi cation of IGFBP4 cDNA, we used forward (5'-gagcgaacatcccaacaaca-3' and reverse (5'-tgcggtcacagtttggaatg-3') primers. Th e nucleotide sequences of these primers correspond to sequences 597-616 and 844-825 of mouse IGFBP4 cDNA (GenBank accession number NM_010517). For amplifi cation of IGFBP5 cDNA, we used forward (5'-gacaggaatccgaacaaggc-3' and reverse (5'-aagtccccatccacgtactc-3') primers. Th e nucleotide sequences of these primers correspond to sequences 1274-1293 and 1505-1486 of mouse IGFBP5 cDNA (GenBank accession number NM_010518).
For amplifi cation of SNARK (SNF1/AMP-activated protein kinase 2 NUAK family; NUAK2) cDNA, we used forward (5'-ccaggcatttcttccgacag-3' and reverse (5'-tcccgttgactatctcaggc-3') primers. Th e nucleotide sequences of these primers correspond to sequences 572-591 and 787-768 of mouse SNARK cDNA (GenBank accession number NM_028778). Th e amplifi cation of PECAM1 (platelet/endothelial cell adhesion molecule 1), also known as CD31 antigen, cDNA for real time RCR analysis was performed using two oligonucleotides primers: forward -5'-agtcagagtcttccttgccc-3' and reverse -5'-agttcagaagtggagcagct-3'. Th e nucleotide sequences of these primers correspond to sequences 1969-1988 and 2135-2116 of mouse PECAM1 cDNA (GenBank accession number NM_001032378). For amplifi cation of CD36 (cluster determinant 36), also known as thrombospondin receptor PAS-4 protein, and fatty acid translocase (FAT), cDNA we used forward (5'-gaatgggctgtgatcggaac-3' and reverse (5'-acgtcatctgggttttgcac-3') primers. Th e nucleotide sequences of these primers correspond to sequences 459-478 and 687-668 of mouse CD36 cDNA (GenBank accession number NM_001159555). Th e amplifi cation of ACTB (beta-actin) cDNA for real time RCR analysis was performed using forward -5'-cctctatgccaacacagtgc-3' and reverse -5'-cctgcttgctgatccacatc-3' primers. Th ese primers nucleotide sequences correspond to 985-1004 and 1190-1171 of mouse ACTB cDNA (NM_007393). Th e expression of beta-actin mRNA was used as control of analyzed RNA quantity. Th e primers were received from Sigma-Aldrich (St. Louis, MO, U.S.A.).
Quantitative PCR analysis was performed using a special computer program "Diff erential expression calculator". Th e values of IGFBP1, IGFBP2, IGFBP3, IGFBP4, IGFBP5, SNARK/NUAK2, CD31/PECAM1, and CD36 gene expressions were normalized to the expression of beta-actin (ACTB) mRNA and represented as percent of control (100%). All values are expressed as mean ± SEM from triplicate measurements performed in four independent experiments. Statistical analysis was performed as described previously (Bochkov et al. 2006) . Th e amplifi ed DNA fragments were also analyzed on a 2% agarose gel and that visualized by SYBR* Safe DNA Gel Stain (Life Technologies, Carlsbad, CA, U.S.A.).
Results
To determine whether a long-term treatment of mice with chromium disilicide or titanium nitride nanoparticles have genotoxic eff ects, we studied the expression level of a subset of genes encoding im- portant regulatory factors, such as IGFBP1, IGFBP2, IGFBP3, IGFBP4, IGFBP5, CD31/PECAM1, and CD36, and enzyme SNARK/NUAK2 in the liver. We showed that long-term treatment of mice by titanium nitride nanoparticles did not signifi cantly change the body weight: before -20.6±0.51 g and aft er 2 months -19.3±0.90 g (n=18), but in the group of control mice, the body weight is signifi cantly increased: before -21.0±0.72 g and aft er 2 months -26.9±1.02 g (+28%; n=20; p<0.01). In mice treated with chromium disilicide nanoparticles, the body weight is slightly decreased: before -20.8±0.73 g and aft er 2 months -18.9±0.93 g (-9%; n=18; p<0.05). Moreover, it is shown that treatment of mice by titanium nitride nanoparticles did not signifi cantly change the expression of IGFBP1 gene, but led to a small but statistically signifi cant down-regulation of IGFBP2 gene expression (-15%) in the liver (Figures 3,  4) . Furthermore, chromium disilicide nanoparticles did not signifi cantly change the expression of IGFBP1 gene, but suppressed the expression of IGFBP2 gene (almost 2-fold) in this tissue (Figures 3, 4) .
We next investigated the eff ect of titanium nitride and chromium disilicide nanoparticles on the expression of IGFBP3 and IGFBP4 genes in mouse liver. We found that expression level of IGFBP3 mRNA is up-regulated (+52%) in the liver of mice treated by titanium nitride nanoparticles in comparison with control animals (Figure 5 ). Similar changes in this gene expression (+49%) were observed in the liver of mice treated by chromium disilicide nanoparticles (Figure 5 ). At the same time, long-term treatment of mice by titanium nitride nanoparticles led to a small but statistically signifi cant up-regulation of the expression of IGFBP4 gene (+19%) in mouse liver in comparison with control animals (Figure 6 ). However, the expression of IGFBP4 gene in the liver of mice treated by chromium disilicide nanoparticles did not change signifi cantly in comparison with control mice ( Figure 6 ). As shown in Figure 7 , the expression of IGFBP5 gene is aff ected in the liver of mice treated by chromium disilicide nanoparticles (-48%) in comparison with control mice. At the same time, this gene expression in mouse liver was resistant to long-term treatment in animals with titanium nitride nanoparticles (Figure 7) .
Moreover, we showed that treatment of mice with titanium nitride nanoparticles led to a strong down- regulation in the expression of SNARK/NUAK2 mRNA (-58%) in the liver (Figure 8 ). Th is fi gure also shows that in mice, treatment with chromium disilicide nanoparticles had more prominent eff ect on this gene expression (-64%) in liver tissue in comparison with control animals. Furthermore, we investigated the eff ect of titanium nitride and chromium disilicide nanoparticles on the expression of CD36/thrombospondin receptor mRNA in mouse liver. As shown in Figure 9 , the expression of this gene is signifi cantly up-regulated (+35%) by titanium nitride nanoparticles in comparison with control mice. Furthermore, stronger changes in the expression of gene encoding CD36 were observed in the liver aft er long-time treatment of mice with chromium disilicide nanoparticles ( Figure 9 ). As shown in Figure 10 , the expression of platelet and endothelial cell adhesion molecule 1 (PECAM1/CD31) mRNA was resistant to long-time treatment of mice with titanium nitride nanoparticles, but strongly down-regulated (-48%) in the group of mice treated with chromium disilicide nanoparticles in comparison with control mice. Th us, long- time treatment of mice with titanium nitride and chromium disilicide nanoparticles has preferentially diff erent eff ect on the expression of a group of genes encoding diff erent IGFBPs, SNARK/NUAK2, CD36, and PECAM1/CD31 (Figure 11 ).
Discussion
In this work, we have studied the eff ect of titanium nitride and chromium disilicide nanoparticles on the expression of a subset of genes encoding different regulatory factors (IGFBP1, IGFBP2, IGFBP3, IGFBP4, IGFBP5, CD36, and PECAM1) and enzyme SNARK/NUAK2, which play an important role in various metabolic pathways and thus control the cell proliferation and apoptosis as well as angiogenesis and metastasis (Praveen Kumar et al. 2014; Baxter 2015; Kim and Lee 2015; Musumeci et al. 2015; Ding et al. 2016; Kim et al. 2016; Miller et al. 2016; Phillips et al. 2016; Guaita-Esteruelas et al. 2017; Pascual et al. 2017) . For titanium dioxide nanoparticles, which are widely used in the number of applications, including cosmetic creams, toothpastes, and component of surgical implants, it has been shown that long-term exposure to these nanoparticles led to accumulation of these nanoparticles in brain, over-proliferation of glial cells and signifi cant changes in brain gene expressions as well as to neurogenic disease states in mice (Ze et al. 2014; Rollerova et al. 2015) . Moreover, titanium dioxide nanoparticles synthesized as nanoneedles, titanate scrolled nanosheets, and gel-sol-based isotropic nanoparticle aff ect intracellular calcium homeostasis, thereby leading to endoplasmic reticulum stressdependent toxicity (Simon et al. 2017) . However, the genotoxicity of titanium nitride nanoparticles, which have favorable properties and are used for coronary stents, syringe needles, and the coating of orthopedic implant as well as in dental medicine for improving long-term implants (van Hove et al. 2015; Chu et al. 2016; Karjalainen and Nammas 2016; Ritz et al. 2016) , has not been studied yet. Very little is known about the toxicity of chromium containing nanoparticles (Alarifi et al. 2016) . In this study, we showed that titanium nitride as well as chromium disilicide nanoparticles may affect the expression of a subset of genes encoding important regulatory factors and enzyme SNARK in mouse liver in a gene-specifi c manner (Figure 11 ). Th us, our data demonstrated that both titanium nitride and chromium disilicide nanoparticles manifest the genotoxic eff ect like titanium dioxide nanoparticles (Ze et al. 2014; Rollerova et al. 2015) , which can contribute to various metabolic abnormalities.
We have shown that longterm treatment of mice with titanium nitride nanoparticles led to an increased expression of 
IGFBP3, IGFBP4
, and CD36 genes in the liver with more prominent changes for IGFBP3 gene. It is well known that proteins encoded by all these genes play an important role in controlling of cell proliferation, apoptosis, cancer growth, and angiogenesis (Praveen Kumar et al. 2014; Bach 2015; Baxter 2015; GuaitaEsteruelas et al. 2017; Pascual et al. 2017) . Moreover, CD36 antigen may also play a role in the pathogenesis of impaired fasting glucose/impaired glucose tolerance and type 2 diabetes (Wang et al. 2012) . Th us, these changes in the expression of IGFBP3, IGFBP4, and CD36 genes, key regulatory factors, in the liver of mice treated with titanium nitride nanoparticles can refl ect the toxic eff ect of titanium nitride and can be responsible for dysregulation of numerous cellular processes. Treatment of mice with chromium disilicide nanoparticles has also led to an increased expression of IGFBP3 and CD36 genes in the liver, but eff ect of these nanoparticles on the expression of CD36 gene was stronger. Th us, these nanoparticles can also introduce various metabolic abnormalities in mice aft er long-term treatment through dysregulation of IGFBP3 and CD36 genes expression.
At the same time, the expression of several genes was suppressed by both titanium nitride and chromium disilicide nanoparticles, but preferentially by chromium disilicide nanoparticles (Figure 11 ). Th us, we also showed that both titanium nitride and chromium disilicide nanoparticles strongly suppress the expression of SNARK/NUAK2 gene in the liver and that the eff ect of chromium disilicide nanoparticles on these gene expressions was stronger in comparison to the eff ect of titanium nitride nanoparticles. It is well known that the enzyme encoded by SNARK gene has variable properties and can contribute to regulation of cell proliferation, apoptosis, and metastasis (Namiki et al. 2011; Sun et al. 2013; Fu et al. 2016; Miller et al. 2016) . Furthermore, we showed that long-term treatment of mice by chromium disilicide nanoparticles only strongly suppressed the expression of IGFBP2 and PECAM1 genes in the liver. It is possible that our results with SNARK/NUAK2, IGFBP2, and PECAM1 genes expression also refl ect the genotoxic eff ect of titanium nitride and chromium disilicide nanoparticles and are mostly consistent with previously reported data (Ze et al. 2014; Alarifi et al. 2016; Yang et al. 2016; Simon et al. 2017) , which clearly demonstrated that titanium dioxide nanoparticles are internalized into the cells, aff ect the expression of numerous genes and disrupt cell metabolic functions, resulting in dysregulation of cell proliferation and apoptosis.
Previously, we have shown that C 60 fullerene and cerium dioxide nanoparticles aff ect the expression of some endoplasmic reticulum stress response genes, which are linked to cell proliferation, cell survival and death (Minchenko et al. 2013a,b) . It was also shown that most of studied genes are endoplasmic reticulum stress responsible (Minchenko and Minchenko 2012 , Minchenko et al. 2015 and changes in the intensity of their expression can refl ect, at least partly, cell stress conditions, because endoplasmic reticulum stress is induced by various toxicants and is an obligate component of numerous pathological processes (Bravo et al. 2013; Han et al. 2013; Manie et al. 2014; Chevet et al. 2015; Dejeans et al. 2015; Maurel et al. 2015) .
In summary, the present study demonstrates that chromium disilicide and titanium nitride nanoparticles had variable eff ects on the expression of most studied genes in a gene specifi c manner, which possibly refl ect the genotoxic activities of studied nanoparticles and their eff ect on important regulatory mechanisms controlling the cell proliferation and survival processes. Moreover, our results suggest that more cautions are needed in biomedical applications of both chromium disilicide and titanium nitride nanoparticles. However, the detailed molecular mechanisms of observed changes in the expression of genes studied require further investigations.
